General Announcement::POLICY D NOTIFICATION TO THE U.S. FDA FOR BIOLIDICS' COVID-19 RAPID TEST KITS-COMPLETION OF LISTING

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Apr-2020 07:11:52
Status
New
Announcement Sub Title
POLICY D NOTIFICATION TO THE U.S. FDA FOR BIOLIDICS' COVID-19 RAPID TEST KITS-COMPLETION OF LISTING
Announcement Reference
SG200420OTHRV9HF
Submitted By (Co./ Ind. Name)
Yee Pinh Jeremy
Designation
Non-Executive Non-Independent Chairman
Description (Please provide a detailed description of the event in the box below)
Please refer to attachment.

Attachments

US FDA Listing Completion.pdf
Total size =87K